Burning mouth syndrome in Parkinson's disease: Dopamine as cure or cause?

Elizabeth Coon, Ruple S. Laughlin

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Burning mouth syndrome has been reported as being more common in Parkinson's disease patients than the general population. While the pathophysiology is unclear, decreased dopamine levels and dopamine dysregulation are hypothesized to play a role. We report a patient with Parkinson's disease who developed burning mouth syndrome with carbidopa/levodopa. Our patient had resolution of burning mouth symptoms when carbidopa/ levodopa was replaced with a dopamine agonist. Based on our patient's clinical course, in conjunction with earlier studies assessing the relationship between burning mouth syndrome and Parkinson's disease, we discuss a potential role for dopamine in burning mouth syndrome in Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)255-257
Number of pages3
JournalJournal of Headache and Pain
Volume13
Issue number3
DOIs
StatePublished - Apr 1 2012

Fingerprint

Burning Mouth Syndrome
Parkinson Disease
Dopamine
Mouth Diseases
Dopamine Agonists
Mouth
Population

Keywords

  • Burning mouth syndrome
  • Carbidopa/levodopa
  • Dopamine
  • Pain
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Burning mouth syndrome in Parkinson's disease : Dopamine as cure or cause? / Coon, Elizabeth; Laughlin, Ruple S.

In: Journal of Headache and Pain, Vol. 13, No. 3, 01.04.2012, p. 255-257.

Research output: Contribution to journalArticle

@article{e96c2a380db042ea825288fb63f82a61,
title = "Burning mouth syndrome in Parkinson's disease: Dopamine as cure or cause?",
abstract = "Burning mouth syndrome has been reported as being more common in Parkinson's disease patients than the general population. While the pathophysiology is unclear, decreased dopamine levels and dopamine dysregulation are hypothesized to play a role. We report a patient with Parkinson's disease who developed burning mouth syndrome with carbidopa/levodopa. Our patient had resolution of burning mouth symptoms when carbidopa/ levodopa was replaced with a dopamine agonist. Based on our patient's clinical course, in conjunction with earlier studies assessing the relationship between burning mouth syndrome and Parkinson's disease, we discuss a potential role for dopamine in burning mouth syndrome in Parkinson's disease.",
keywords = "Burning mouth syndrome, Carbidopa/levodopa, Dopamine, Pain, Parkinson's disease",
author = "Elizabeth Coon and Laughlin, {Ruple S.}",
year = "2012",
month = "4",
day = "1",
doi = "10.1007/s10194-012-0421-1",
language = "English (US)",
volume = "13",
pages = "255--257",
journal = "Journal of Headache and Pain",
issn = "1129-2369",
publisher = "Springer-Verlag Italia",
number = "3",

}

TY - JOUR

T1 - Burning mouth syndrome in Parkinson's disease

T2 - Dopamine as cure or cause?

AU - Coon, Elizabeth

AU - Laughlin, Ruple S.

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Burning mouth syndrome has been reported as being more common in Parkinson's disease patients than the general population. While the pathophysiology is unclear, decreased dopamine levels and dopamine dysregulation are hypothesized to play a role. We report a patient with Parkinson's disease who developed burning mouth syndrome with carbidopa/levodopa. Our patient had resolution of burning mouth symptoms when carbidopa/ levodopa was replaced with a dopamine agonist. Based on our patient's clinical course, in conjunction with earlier studies assessing the relationship between burning mouth syndrome and Parkinson's disease, we discuss a potential role for dopamine in burning mouth syndrome in Parkinson's disease.

AB - Burning mouth syndrome has been reported as being more common in Parkinson's disease patients than the general population. While the pathophysiology is unclear, decreased dopamine levels and dopamine dysregulation are hypothesized to play a role. We report a patient with Parkinson's disease who developed burning mouth syndrome with carbidopa/levodopa. Our patient had resolution of burning mouth symptoms when carbidopa/ levodopa was replaced with a dopamine agonist. Based on our patient's clinical course, in conjunction with earlier studies assessing the relationship between burning mouth syndrome and Parkinson's disease, we discuss a potential role for dopamine in burning mouth syndrome in Parkinson's disease.

KW - Burning mouth syndrome

KW - Carbidopa/levodopa

KW - Dopamine

KW - Pain

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84861483723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861483723&partnerID=8YFLogxK

U2 - 10.1007/s10194-012-0421-1

DO - 10.1007/s10194-012-0421-1

M3 - Article

C2 - 22322657

AN - SCOPUS:84861483723

VL - 13

SP - 255

EP - 257

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

SN - 1129-2369

IS - 3

ER -